Back
Annovis Bio 10K Form
Sell
43
ANVS
Annovis Bio
Last Price:
5.60
Seasonality Move:
32.1%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ANVS News And Ratings
See the #1 stock for the next 7 days that we like better than ANVS
ANVS Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-9.37M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.74 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -6.22000 |
|---|---|
| Net Income (TTM): | $-56.2M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Annovis Bio Earnings Forecast
Key Annovis Bio Financial Ratios
- Per Share Earnings over the last 7 years have been positive in 0 years.
Annovis Bio Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ANVS |
| CUSIP: | 03615A |
| Website: | annovisbio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ANVS Technical Analysis vs Fundamental Analysis
Sell
43
Annovis Bio (ANVS)
is a Sell
Is Annovis Bio a Buy or a Sell?
-
Annovis Bio stock is rated a Sell
The current Annovis Bio [ANVS] share price is $5.45. The Score for ANVS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.